Entera Bio Future Growth
Future criteria checks 0/6
Entera Bio's earnings are forecast to decline at 61.5% per annum. EPS is expected to decline by 31.9% per annum.
Key information
-61.5%
Earnings growth rate
-31.9%
EPS growth rate
| Biotechs earnings growth | 21.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 02 Apr 2024 |
Recent future growth updates
Recent updates
Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Mar 23
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
May 31Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely?
Feb 15Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?
Oct 13Entera Bio GAAP EPS of -$0.24 , revenue of $0.11M
Aug 11We Think Entera Bio (NASDAQ:ENTX) Needs To Drive Business Growth Carefully
Jun 10Companies Like Entera Bio (NASDAQ:ENTX) Are In A Position To Invest In Growth
Jan 21We're Interested To See How Entera Bio (NASDAQ:ENTX) Uses Its Cash Hoard To Grow
Oct 06Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Jun 19Entera Bio secures European patent for oral PTH formulations
Jun 17We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Mar 20Here's Why Entera Bio (NASDAQ:ENTX) Must Use Its Cash Wisely
Dec 05
Entera Bio EPS misses by $0.22
Nov 19Entera Bio completes enrollment in Phase 2 trial of EB613 in Osteoporosis
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -28 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -10 | N/A | N/A | 1 |
| 12/31/2023 | N/A | -9 | -7 | -7 | N/A |
| 9/30/2023 | 0 | -10 | -7 | -7 | N/A |
| 6/30/2023 | 0 | -11 | -8 | -8 | N/A |
| 3/31/2023 | 0 | -11 | -9 | -9 | N/A |
| 12/31/2022 | 0 | -13 | -13 | -12 | N/A |
| 9/30/2022 | 0 | -14 | -13 | -13 | N/A |
| 6/30/2022 | 0 | -14 | -12 | -12 | N/A |
| 3/31/2022 | 0 | -14 | -12 | -12 | N/A |
| 12/31/2021 | 1 | -12 | -9 | -9 | N/A |
| 9/30/2021 | 1 | -12 | -8 | -8 | N/A |
| 6/30/2021 | 1 | -10 | -9 | -9 | N/A |
| 3/31/2021 | 0 | -11 | -10 | -10 | N/A |
| 12/31/2020 | 0 | -11 | -11 | -11 | N/A |
| 9/30/2020 | 0 | -11 | -12 | -12 | N/A |
| 6/30/2020 | 0 | -13 | -11 | -11 | N/A |
| 3/31/2020 | 0 | -11 | -10 | -10 | N/A |
| 12/31/2019 | 0 | -11 | -9 | -9 | N/A |
| 9/30/2019 | 1 | -10 | -8 | -8 | N/A |
| 6/30/2019 | 1 | -12 | -9 | -9 | N/A |
| 3/31/2019 | 1 | -9 | -9 | -9 | N/A |
| 12/31/2018 | 1 | -10 | -10 | -10 | N/A |
| 9/30/2018 | N/A | -11 | -9 | -9 | N/A |
| 6/30/2018 | N/A | -10 | -8 | -8 | N/A |
| 3/31/2018 | N/A | -13 | -6 | -6 | N/A |
| 12/31/2017 | N/A | -11 | -5 | -5 | N/A |
| 9/30/2017 | N/A | -8 | N/A | -4 | N/A |
| 6/30/2017 | N/A | -6 | N/A | -4 | N/A |
| 3/31/2017 | N/A | -4 | N/A | -4 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ENTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ENTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if ENTX's revenue is forecast to grow faster than the US market.
High Growth Revenue: ENTX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ENTX's Return on Equity is forecast to be high in 3 years time